|
CHCHD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.16371365269197E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.27330043678364E-10 |
| Normal-vs-Stage2 |
4.24290000022864E-07 |
| Normal-vs-Stage3 |
6.15849999885398E-08 |
| Normal-vs-Stage4 |
1.092750E-01 |
| Stage1-vs-Stage2 |
1.535150E-01 |
| Stage1-vs-Stage3 |
8.748100E-02 |
| Stage1-vs-Stage4 |
6.418000E-01 |
| Stage2-vs-Stage3 |
9.420600E-01 |
| Stage2-vs-Stage4 |
1.947350E-01 |
| Stage3-vs-Stage4 |
1.721780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.16437978650674E-12 |
| Normal-vs-AfricanAmerican |
5.61809999966023E-07 |
| Normal-vs-Asian |
1.023960E-01 |
| Caucasian-vs-AfricanAmerican |
6.748600E-01 |
| Caucasian-vs-Asian |
8.083200E-01 |
| AfricanAmerican-vs-Asian |
7.479400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.95365945643289E-12 |
| Normal-vs-Female |
5.97570004590153E-09 |
| Male-vs-Female |
4.513800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.64430025151319E-10 |
| Normal-vs-Extreme_Weight |
3.95909971473429E-11 |
| Normal-vs-Obese |
1.53660000279388E-08 |
| Normal-vs-Extreme_Obese |
7.082400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.627600E-01 |
| Normal_Weight-vs-Obese |
5.404600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.083600E-01 |
| Extreme_Weight-vs-Obese |
8.085400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.463400E-01 |
| Obese-vs-Extreme_Obese |
2.742400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.039500E-03 |
| Normal-vs-Age(41-60Yrs) |
7.44992956214219E-12 |
| Normal-vs-Age(61-80Yrs) |
1.87120319239398E-11 |
| Normal-vs-Age(81-100Yrs) |
1.48269951871782E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.665200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.387200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.971800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.105600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.412100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.904000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.20909948719827E-11 |
| Normal-VS-Type2 PRCC |
3.17019999140911E-09 |
| Normal-VS-KIRP CIMP |
1.438720E-04 |
| Normal-VS-Unclassified PRCC |
3.05240277498342E-11 |
| Type1 PRCC-VS-Type2 PRCC |
4.201200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.419400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.921800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.302400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.680590E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.176390E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.17299503443746E-11 |
| Normal-vs-N1 |
1.380740E-04 |
| Normal-vs-N2 |
2.32180000003801E-07 |
| N0-vs-N1 |
4.804800E-01 |
| N0-vs-N2 |
4.108200E-01 |
| N1-vs-N2 |
3.262600E-01 |
|
|
